Cynata Therapeutics Limited(AU:CYP)
A$0.01-0.00 (-7.14%)
AU:CYP
Cynata Therapeutics Limited financials statements
A$0.01
At close:-0.00 (-7.14%)
Want to see AU:CYP full AI Analyst Report?
Cynata Therapeutics Limited (CYP) Income Statement
11 Followers
Cynata Therapeutics Limited Income Statement
Last quarter (Q4 2026), Cynata Therapeutics Limited's total revenue was AU$0.00, an increase of 100.00% from the same quarter last year. In Q4, Cynata Therapeutics Limited's net income was AU$-6.59M. See Cynata Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 1.71M | AU$ 1.89M | AU$ 2.32M | AU$ 1.65M | AU$ 7.77M | |
| AU$ -260.31K | AU$ 1.89M | AU$ 2.32M | AU$ 1.37M | AU$ 7.49M | |
| AU$ 9.42M | AU$ 10.01M | AU$ 11.12M | AU$ 16.26M | AU$ 12.06M | |
| Depreciation and Amortization | AU$ 260.31K | AU$ 282.96K | AU$ 280.73K | AU$ 279.96K | AU$ 279.96K |
| AU$ -9.42M | AU$ -9.33M | AU$ -9.95M | AU$ -15.65M | AU$ -6.00M | |
| AU$ -9.68M | AU$ -8.12M | AU$ -8.81M | AU$ -16.54M | AU$ -6.90M | |
| AU$ -1.28M | AU$ -1.27M | AU$ -3.25M | AU$ 610.71K | AU$ 622.45K | |
| AU$ -10.96M | AU$ -9.39M | AU$ -12.06M | AU$ -15.93M | AU$ -6.28M | |
| AU$ -9.25M | AU$ -9.39M | AU$ -9.74M | AU$ -14.28M | AU$ -5.45M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.04 | AU$ -0.05 | AU$ -0.05 | AU$ -0.10 | AU$ -0.04 |
| Diluted EPS | AU$ -0.04 | AU$ -0.05 | AU$ -0.05 | AU$ -0.10 | AU$ -0.04 |
| Weighted Average Shares Outstanding | 236.70M | 204.95M | 179.63M | 145.09M | 143.28M |
| Weighted Average Shares Outstanding (Diluted) | 236.70M | 204.95M | 179.63M | 145.09M | 143.28M |
Currency in AUD
